0000899243-20-000608.txt : 20200106 0000899243-20-000608.hdr.sgml : 20200106 20200106171953 ACCESSION NUMBER: 0000899243-20-000608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 20510909 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001098972 AGENUS INC AGEN 0001187314 WIINBERG ULF C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Deferred Stock Units 2020-01-02 4 A 0 5667.535 A Common Stock 5667.535 67410.805 D Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. $3.419 per Deferred Stock Unit acquired on January 2, 2020. The price of each Deferred Stock Unit acquired prior to January 2, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. /s/Evan D. Kearns, as Attorney-in-Fact for Ulf Wiinberg 2020-01-06